A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Abroad (travel likely)RecruitingPHASE2

Conditions

Chronic Hepatitis B

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Zuo · yyyyecp1@163.com · 010-63139003

Study leads

Jia
Principal Investigator
Beijing Friendship Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Chronic Hepatitis B

Abroad (travel likely)RecruitingPHASE2

Jilin City, China

Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon

Chronic Hepatitis B

Abroad (travel likely)Recruiting

Beijing, China

A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis

Chronic Hepatitis B-related Liver Fibrosis

Abroad (travel likely)RecruitingPHASE2

Chongqing, China

A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)

Chronic Hepatitis b · Anti-PD-1 Antibody

Abroad (travel likely)RecruitingPHASE2

Chongqing, China